Epstein-Barr virus lymphoblastoid cell lines from transplanted patients induce B lymphomas in SCID/hu mice: study of EBV replication
Blanc-Brunat, N.; Laurin, D.; Vivier, G.; Touraine, J.L.; Sergeant, A.; Garnier, J.L.
Transplantation Proceedings 27(2): 1776
1995
ISSN/ISBN: 0041-1345 PMID: 7725498 Document Number: 440266
Document emailed within 1 workday
Related Documents
Zarling, J.M.; Dierckins, M.S.; Sevenich, E.A.; Clouse, K.A. 1981: Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations Journal of Immunology 127(5): 2118-2123Hamilton-Dutoit, S.J.; Pallesen, G. 1992: A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas American Journal of Pathology 140(6): 1315-1325
Giunta, S.; Groppa, G. 1983: New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines Cancer Research 43(11): 5064-5067
Tsuchiya, S.; Yokoyama, S.; Yoshie, O.; Ono, Y. 1980: Production of diphtheria antitoxin antibody in Epstein-Barr virus-induced lymphoblastoid cell lines Journal of Immunology 124(4): 1970-1976
Yamamoto, N.; Mitsuma, T.; Vogt, A. 1982: Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines Journal of the National Cancer Institute 68(3): 385-390
Larrat, S.; Morand, P.; Bas, A.; Vigne, S.; Crance, J.-M.; Boyer, V.ér.; Nicod, S.; Grossi, L.; Buisson, M.; Burmeister, W.P.; Seigneurin, J.-M.; Germi, R.ël. 2009: Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene Antiviral Therapy 14(5): 655-662
Liu, A.; Jiang, Y.; Zhao, K. 1999: The effect of EBNA-1 ribozyme on the ability of tumor genesis of lymphoblastoid cell lines in SCID mice Zhonghua Yi Xue Za Zhi 79(7): 538-541
Roubal, J.; Roubalová, K. 1985: Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus Acta Virologica 29(2): 162-165
Rickinson, A.B.; Murray, R.J.; Brooks, J.; Griffin, H.; Moss, D.J.; Masucci, M.G. 1992: T cell recognition of Epstein-Barr virus associated lymphomas Cancer Surveys 13: 53-80
Kanavaros, P.; Briere, J.; Emile, J.F.; Gaulard, P. 1996: Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas Leukemia 10(Suppl): S84-S87
Fujita, J.; Yoshida, O. 1984: Failure to activate Epstein-Barr virus genome in a latently-infected human lymphoblastoid cell line with urine containing a bladder carcinogenesis promoter Hinyokika Kiyo. Acta Urologica Japonica 30(7): 897-901
Cohen, J.H.; Revillard, J.P.; Magaud, J.P.; Lenoir, G.; Vuillaume, M.; Manel, A.M.; Vincent, C.; Bryon, P.A. 1987: B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation Journal of the National Cancer Institute 78(2): 235-242
Roncella, S.; Di Celle, P.F.; Cutrona, G.; Carbone, A.; Sessarego, M.; Dodi, F.; Foa, R.; Rowe, M.; Ferrarini, M. 1992: Characterization of EBV-positive lymphoblastoid cell lines obtained from HIV seropositive patients with or without lymphomas Leukemia 6(Suppl 3): 12s-14s
Inada, M.; Yamashita, J.; Ogawa, M. 1997: Neutrophil elastase inhibitor (ONO-5046-Na) inhibits the growth of human lung cancer cell lines transplanted into severe combined immunodeficiency (scid) mice Research Communications in Molecular Pathology and Pharmacology 97(2): 229-232
Wolf, J.; Pawlita, M.; Bullerdiek, J.; zur Hausen, H. 1990: Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression Cancer Research 50(10): 3095-3100
Skibiński, G.; James, K. 1989: Reactivation of antibody genes in Epstein-Barr virus transformed human B cell lines. A preliminary report Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 295-300
Serebrianaia, N.B.; Zhiburt, E.B.; Novik, A.A.; Voloshin, S.V.; Krivolapov, I.A.; Katkova, I.V.; D'iakova, V.V.; Ziuz'gin, I.S.; Sanzharevskiĭ, V.A. 1998: Connection between Epstein-Barr virus infection and HLA phenotype and features of cytokine status in patients with non-Hodgkin's lymphomas Voprosy Virusologii 43(2): 79-82
Suchánková, A.; Vonka, V. 1978: UV-inactivation of Epstein-Barr virus: differences in early antigen expression in two different non-productive cell lines and influence of caffeine Acta Virologica 22(5): 383-390
Liu, M.Y.; Chen, J.Y.; Yang, C.S. 1984: Activity of DNase associated with replication of Epstein-Barr virus in NPC-204 cells Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 17(3): 121-130
Boyle, T.J.; Tamburini, M.; Berend, K.R.; Kizilbash, A.M.; Borowitz, M.J.; Lyerly, H.K. 1992: Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus Surgery 112(2): 378-386